CD133 expression is correlated with chemoresistance and early recurrence of gastric cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD133 expression is correlated with chemoresistance and early recurrence of gastric cancer
Authors
Keywords
-
Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 106, Issue 8, Pages 999-1004
Publisher
Wiley
Online
2012-06-05
DOI
10.1002/jso.23178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation
- (2011) Hiroshi Fukamachi et al. CANCER SCIENCE
- Current molecular markers for gastric progenitor cells and gastric cancer stem cells
- (2011) Xiaotan T. Qiao et al. JOURNAL OF GASTROENTEROLOGY
- Cancer Stem Cells: Characteristics and Their Potential Role for New Therapeutic Strategies
- (2011) Stephan R. Bohl et al. ONKOLOGIE
- Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma
- (2010) Po Zhao et al. BMC CANCER
- Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
- (2010) Ji-wei Yu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CD133 mRNA expression and microsatellite instability in colorectal carcinoma
- (2010) Jung Wook Huh et al. JOURNAL OF SURGICAL ONCOLOGY
- CD133 expression in different stages of gastric adenocarcinoma
- (2009) M Boegl et al. BRITISH JOURNAL OF CANCER
- The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer☆☆☆
- (2009) Virginia Tirino et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Targeting CD133 antigen in cancer
- (2009) Gabriella Ferrandina et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
- (2008) L M Smith et al. BRITISH JOURNAL OF CANCER
- CD133 expression is an independent prognostic marker for low survival in colorectal cancer
- (2008) D Horst et al. BRITISH JOURNAL OF CANCER
- CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer
- (2008) S Maeda et al. BRITISH JOURNAL OF CANCER
- Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study
- (2008) Motohiro Kojima et al. CANCER SCIENCE
- Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma
- (2008) W. Song et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started